TIAA CREF INVESTMENT MANAGEMENT LLC - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 44 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
TIAA CREF INVESTMENT MANAGEMENT LLC ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q1 2019$1,766,000
-28.8%
43,977
-18.4%
0.00%
-50.0%
Q4 2018$2,480,000
-50.4%
53,920
-52.2%
0.00%0.0%
Q3 2018$5,000,000
+153.9%
112,694
+124.3%
0.00%
+100.0%
Q2 2018$1,969,000
-30.7%
50,241
+27.8%
0.00%
-50.0%
Q1 2018$2,843,000
+14.3%
39,300
+4.0%
0.00%0.0%
Q4 2017$2,488,000
+17.5%
37,792
-10.6%
0.00%
+100.0%
Q3 2017$2,118,000
+17.1%
42,254
+8.1%
0.00%0.0%
Q2 2017$1,808,000
+35.0%
39,074
+3.0%
0.00%0.0%
Q1 2017$1,339,000
+174.9%
37,926
-2.5%
0.00%
Q4 2016$487,000
-22.3%
38,910
-14.1%
0.00%
Q3 2016$627,000
+40.0%
45,3050.0%0.00%
Q2 2016$448,000
-38.3%
45,305
+5.5%
0.00%
-100.0%
Q1 2016$726,000
-40.7%
42,935
-22.0%
0.00%0.0%
Q4 2015$1,225,000
-6.6%
55,021
-1.0%
0.00%0.0%
Q3 2015$1,312,000
-62.9%
55,596
+28.7%
0.00%
-66.7%
Q2 2015$3,532,000
+62.0%
43,205
+83.5%
0.00%
+50.0%
Q1 2015$2,180,000
+174.9%
23,543
+20.1%
0.00%
+100.0%
Q4 2014$793,000
+64.5%
19,609
-0.4%
0.00%
Q3 2014$482,000
+54.5%
19,6950.0%0.00%
Q2 2014$312,000
+25.3%
19,695
+19.7%
0.00%
Q1 2014$249,000
+85.8%
16,458
+68.7%
0.00%
Q4 2013$134,000
-27.2%
9,7580.0%0.00%
Q3 2013$184,0009,7580.00%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q4 2013
NameSharesValueWeighting ↓
Meditor Group Ltd 2,818,835$33,967,00011.67%
PLATINUM INVESTMENT MANAGEMENT LTD 1,713,176$20,644,0000.58%
Bellevue Group AG 4,519,164$54,455,0000.55%
Rhenman & Partners Asset Management AB 622,267$7,498,0000.53%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 47,534$573,0000.21%
WASATCH ADVISORS LP 3,274,360$39,456,0000.16%
EMC Capital Management 27,566$246,0000.14%
PDT Partners, LLC 120,828$1,456,0000.10%
Virtus ETF Advisers LLC 17,773$214,0000.09%
Pinz Capital Management, LP 15,300$184,0000.08%
View complete list of ESPERION THERAPEUTICS INC NE shareholders